13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0000904454-24-000604
Total Value
$427.3M
Positions
20
Other Managers
1
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $110.2M | 25.79% |
| 2 | Rapport Therapeutics, Inc. | RAPP | 2,498,051 | $51.2M | 11.97% |
| 3 | Legend Biotech Corporation | LEGN | 814,586 | $39.7M | 9.29% |
| 4 | Contineum Therapeutics Inc. | CTNM | 1,979,173 | $37.9M | 8.86% |
| 5 | CVRx, Inc. | CVRX | 4,103,430 | $36.2M | 8.46% |
| 6 | Nanobiotix S.A. | NBTX | 5,623,816 | $32.3M | 7.57% |
| 7 | Procept BioRobotics Corporation | PRCT | 357,939 | $28.7M | 6.71% |
| 8 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $27.7M | 6.48% |
| 9 | Neumora Therapeutics, Inc. | NMRA | 1,849,445 | $24.4M | 5.72% |
| 10 | Xencor, Inc. | XNCR | 748,062 | $15.0M | 3.52% |
| 11 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $11.8M | 2.77% |
| 12 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $4.8M | 1.12% |
| 13 | Rallybio Corporation | RLYB | 3,636,363 | $4.3M | 1.00% |
| 14 | Nano-X Imaging Ltd. | NNOX | 158,852 | $965,820 | 0.23% |
| 15 | Vor Biopharma, Inc. | VOR | 1,074,658 | $752,261 | 0.18% |
| 16 | Standard BioTools Inc | LAB | 311,967 | $602,096 | 0.14% |
| 17 | Adicet Bio, Inc. | ACET | 364,472 | $524,840 | 0.12% |
| 18 | BiomX Inc. | PHGE | 192,321 | $196,167 | 0.05% |
| 19 | Clearside Biomedical, Inc. | CLSDQ | 82,481 | $104,751 | 0.02% |
| 20 | Senseonics Holdings, Inc. | SENS | 54,621 | $19,101 | 0.00% |